Road Map for Development of Stem Cell-Based Alternative Test Methods
- 1 June 2019
- journal article
- review article
- Published by Elsevier in Trends in Molecular Medicine
- Vol. 25 (6) , 470-481
Abstract
No abstract availableKeywords
This publication has 54 references indexed in Scilit:
- Recent advances in 2D and 3D in vitro systems using primary hepatocytes, alternative hepatocyte sources and non-parenchymal liver cells and their use in investigating mechanisms of hepatotoxicity, cell signaling and ADMEArchives of Toxicology, 2013
- Human embryonic stem cell-derived test systems for developmental neurotoxicity: a transcriptomics approachArchives of Toxicology, 2012
- Identification of Thalidomide-Specific Transcriptomics and Proteomics Signatures during Differentiation of Human Embryonic Stem CellsPLOS ONE, 2012
- Robust cardiomyocyte differentiation from human pluripotent stem cells via temporal modulation of canonical Wnt signalingProceedings of the National Academy of Sciences, 2012
- Mechanisms of Aminoglycoside Ototoxicity and Targets of Hair Cell ProtectionInternational Journal of Otolaryngology, 2011
- Teratogen screening using transcriptome profiling of differentiating human embryonic stem cellsJournal of Cellular and Molecular Medicine, 2011
- Establishment of Intestinal Identity and Epithelial-Mesenchymal Signaling by Cdx2Developmental Cell, 2009
- Why animal studies are often poor predictors of human reactions to exposureJournal of the Royal Society of Medicine, 2009
- A systematic review of NSAIDs withdrawn from the market due to hepatotoxicity: lessons learned from the bromfenac experiencePharmacoepidemiology and Drug Safety, 2006
- Pharmacokinetic Drug Interactions with Oral ContraceptivesClinical Pharmacokinetics, 1990